Thanks Alex! I think an important advantage of the D2C model is that the product would easily fit into Google Search's business model (more time spent on Search due to this tool = more ad dollars). However, it will be difficult for Google to monetize the specific data captured from users for this tool, since that data would probably fall under health privacy regulations and require user consent. As we have seen with other opt-in systems for data tracking (like Apple iOS 14), almost all users will likely decide to opt-out (https://arstechnica.com/gadgets/2021/05/96-of-us-users-opt-out-of-app-tracking-in-ios-14-5-analytics-find/).
Great writeup! If Google Health were to go D2C, what do you think should be their business model?
Thanks Alex! I think an important advantage of the D2C model is that the product would easily fit into Google Search's business model (more time spent on Search due to this tool = more ad dollars). However, it will be difficult for Google to monetize the specific data captured from users for this tool, since that data would probably fall under health privacy regulations and require user consent. As we have seen with other opt-in systems for data tracking (like Apple iOS 14), almost all users will likely decide to opt-out (https://arstechnica.com/gadgets/2021/05/96-of-us-users-opt-out-of-app-tracking-in-ios-14-5-analytics-find/).